Cargando…
Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice
BACKGROUND: Doxorubicin (Dox) is a potent chemotherapeutic agent, but its usage is limited by dose-dependent cardiotoxicity. Intracellular calcium dysregulation has been reported to be involved in doxorubicin-induced cardiomyopathy (DICM). The cardioprotective role of RyR stabilizer dantrolene (Dan)...
Autores principales: | Azam, Mohammed Ali, Chakraborty, Praloy, Bokhari, Mahmoud M., Dadson, Keith, Du, Beibei, Massé, Stéphane, Si, Daoyuan, Niri, Ahmed, Aggarwal, Arjun K., Lai, Patrick F.H., Riazi, Sheila, Billia, Filio, Nanthakumar, Kumaraswamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710625/ https://www.ncbi.nlm.nih.gov/pubmed/34988524 http://dx.doi.org/10.1016/j.hroo.2021.08.008 |
Ejemplares similares
-
Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
por: Fernandes, Amanda D.F., et al.
Publicado: (2021) -
Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats
por: Du, Beibei, et al.
Publicado: (2020) -
Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2
por: Dadson, Keith, et al.
Publicado: (2022) -
Synchronizing systolic calcium release with azumolene in an experimental model
por: Si, Daoyuan, et al.
Publicado: (2022) -
Uncoupling cytosolic calcium from membrane voltage by transient receptor potential melastatin 4 channel (TRPM4) modulation: A novel strategy to treat ventricular arrhythmias
por: Chakraborty, Praloy, et al.
Publicado: (2023)